- Can-Fite BioPharma (CANF) +75% and Gebro Pharma on development & commercialization of phase III drug candidate Piclidenoson in the treatment of Rheumatoid Arthritis.
- Hepion Pharmaceuticals (HEPA) +54% on encouraging CRV431 data.
- Cronos Group (CRON) +25% following block trades.
- Rekor Systems (REKR) +14% on being selected by the United States Air Force to deploy its industry leading vehicle recognition system within a western United States base.
- Avita Medical (RCEL) +11%.
- Tata Motors (TTM) +8%.
- Netflix (NFLX) +8% on Q3 results.
- Central European Media Enterprises (CETV) +6% on Q3 results.
- Telefonaktiebolaget LM Ericsson(ERIC) +7% on Q3 results.
- Ocugen (OCGN) +4%.
- Alcoa (AA) +5% on Q3 results.
- Top Ships (TOPS) +5%.
- Aurora Cannabis (ACB) +5% on plans for NextGen cannabis products.